G. E. Hardee

981 total citations
17 papers, 792 citations indexed

About

G. E. Hardee is a scholar working on Molecular Biology, Small Animals and Pharmacology. According to data from OpenAlex, G. E. Hardee has authored 17 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Small Animals and 5 papers in Pharmacology. Recurrent topics in G. E. Hardee's work include RNA Interference and Gene Delivery (7 papers), Inflammatory mediators and NSAID effects (4 papers) and Veterinary Equine Medical Research (4 papers). G. E. Hardee is often cited by papers focused on RNA Interference and Gene Delivery (7 papers), Inflammatory mediators and NSAID effects (4 papers) and Veterinary Equine Medical Research (4 papers). G. E. Hardee collaborates with scholars based in United States, Germany and Ireland. G. E. Hardee's co-authors include James N. Moore, Lloyd Tillman, Roland Bodmeier, Maris Hardee, Susan D. Semrad, Richard S. Geary, Andrei Dashevsky, Rosie Z. Yu, Arthur A. Levin and J. A. Smith and has published in prestigious journals such as Journal of Controlled Release, International Journal of Pharmaceutics and Journal of Pharmaceutical Sciences.

In The Last Decade

G. E. Hardee

17 papers receiving 748 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. E. Hardee United States	13	296	153	143	135	100	17	792
Thomas K. Petersen Denmark	15	224 0.8×	78 0.5×	13 0.1×	26 0.2×	71 0.7×	34	857
Katsuhiko Konno Japan	13	191 0.6×	40 0.3×	10 0.1×	35 0.3×	20 0.2×	27	796
Yahya Alhamhoom Saudi Arabia	13	189 0.6×	126 0.8×	7 0.0×	37 0.3×	26 0.3×	48	503
Levent Dirikolu United States	16	186 0.6×	6 0.0×	115 0.8×	100 0.7×	182 1.8×	67	719
M.K. Prinsen Netherlands	16	264 0.9×	43 0.3×	2 0.0×	46 0.3×	254 2.5×	30	900
Radhakrishna Sura United States	16	201 0.7×	33 0.2×	2 0.0×	30 0.2×	66 0.7×	28	792
Jair Adriano Kopke de Aguiar Brazil	13	142 0.5×	3 0.0×	39 0.3×	20 0.1×	89 0.9×	33	617
Mohammad Hashemnia Iran	18	169 0.6×	4 0.0×	7 0.0×	49 0.4×	123 1.2×	83	921
Madhu Sudhan Shaik United States	14	117 0.4×	124 0.8×		97 0.7×	26 0.3×	17	515
Felipe Varum United Kingdom	18	274 0.9×	513 3.4×	2 0.0×	37 0.3×	5 0.1×	23	1.1k

Countries citing papers authored by G. E. Hardee

Since Specialization

Citations

This map shows the geographic impact of G. E. Hardee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. E. Hardee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. E. Hardee more than expected).

Fields of papers citing papers by G. E. Hardee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. E. Hardee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. E. Hardee. The network helps show where G. E. Hardee may publish in the future.

Co-authorship network of co-authors of G. E. Hardee

This figure shows the co-authorship network connecting the top 25 collaborators of G. E. Hardee. A scholar is included among the top collaborators of G. E. Hardee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. E. Hardee. G. E. Hardee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Raoof, Araz, Pky Chiu, Zebunnissa Ramtoola, et al.. (2004). Oral bioavailability and multiple dose tolerability of an antisense oligonucleotide tablet formulated with sodium caprate. Journal of Pharmaceutical Sciences. 93(6). 1431–1439. 67 indexed citations

Mathew, E., et al.. (2003). Cytosolic delivery of antisense oligonucleotides by listeriolysin O-containing liposomes. Gene Therapy. 10(13). 1105–1115. 37 indexed citations

Geary, Richard S., Rosie Z. Yu, Tanya Watanabe, et al.. (2003). PHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIES. Drug Metabolism and Disposition. 31(11). 1419–1428. 141 indexed citations

Raoof, Araz, et al.. (2002). Effect of sodium caprate on the intestinal absorption of two modified antisense oligonucleotides in pigs. European Journal of Pharmaceutical Sciences. 17(3). 131–138. 52 indexed citations

Tillman, Lloyd, et al.. (2002). Characterization of alginate/poly-l-lysine particles as antisense oligonucleotide carriers. International Journal of Pharmaceutics. 239(1-2). 47–59. 49 indexed citations

Tillman, Lloyd, et al.. (2001). Characterization of complexes of an antisense oligonucleotide with protamine and poly-l-lysine salts. Journal of Controlled Release. 73(2-3). 381–390. 25 indexed citations

Dashevsky, Andrei, et al.. (2000). Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microspheres. Journal of Controlled Release. 69(1). 197–207. 121 indexed citations

Trim, Cynthia Μ., et al.. (1991). Effects of an infusion of dopamine on the cardiopulmonary effects of Escherichia coli endotoxin in anaesthetised horses. Research in Veterinary Science. 50(1). 54–63. 14 indexed citations

Semrad, Susan D., et al.. (1987). Low dose flunixin meglumine: Effects on eicosanoid production and clinical signs induced by experimental endotoxaemia in horses. Equine Veterinary Journal. 19(3). 201–206. 83 indexed citations

10.

Hardee, G. E., et al.. (1987). HPLC determination and pharmacokinetics of thiabendazole and its major metabolite 5-OH thiabendazole in equine plasma. Research in Veterinary Science. 43(1). 13–17. 4 indexed citations

11.

Hardee, Maris, James N. Moore, & G. E. Hardee. (1986). Effects of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor (UK-38,485) on thromboxane and prostacyclin production in healthy horses. Research in Veterinary Science. 40(2). 152–156. 23 indexed citations

12.

Semrad, Susan D., Cynthia Μ. Trim, & G. E. Hardee. (1986). Hypertension in bulls and steers anesthetized with guaifenesin-thiobarbiturate-halothane combination. American Journal of Veterinary Research. 47(7). 1577–1582. 10 indexed citations

13.

Moore, James N., Maris Hardee, & G. E. Hardee. (1986). Modulation of arachidonic acid metabolism in endotoxic horses: Comparison of flunixin meglumine, phenylbutazone, and a selective thromboxane synthetase inhibitor. American Journal of Veterinary Research. 47(1). 110–113. 40 indexed citations

14.

Trim, Cynthia Μ., et al.. (1985). Cardiopulmonary effects of prostacyclin infusion in anesthetized horses. American Journal of Veterinary Research. 46(4). 928–931. 5 indexed citations

15.

Semrad, Susan D., G. E. Hardee, Maris Hardee, & James N. Moore. (1985). Flunixin meglumine given in small doses: Pharmacokinetics and prostaglandin inhibition in healthy horses. American Journal of Veterinary Research. 46(12). 2474–2479. 66 indexed citations

16.

Hardee, G. E., et al.. (1985). Simultaneous Determination of Phenylbutazone, Flunixin, Indomethacin and 4 Methylaminoantipyrene with Novel use of an Ion-Pairing Step-Gradient HPLC Methodology. Analytical Letters. 18(15). 1897–1904. 5 indexed citations

17.

Hardee, G. E., J. A. Smith, & Stephanie J. Harris. (1985). Pharmacokinetics of flunixin meglumine in the cow. Research in Veterinary Science. 39(1). 110–112. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact